Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | BRIP1 |
| Variant | Q685* |
| Impact List | nonsense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | BRIP1 Q685* results in a premature truncation of the Brip1 protein at amino acid 685 of 1249 (UniProt.org). Q685* does not confer resistance to interstrand crosslinking agents in a BRIP1-deficient cell line in culture (PMID: 33619228), and therefore, is predicted to lead to a loss of Brip1 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
BRIP1 mutant BRIP1 inact mut BRIP1 Q685* |
| Transcript | NM_032043.3 |
| gDNA | chr17:g.61776445G>A |
| cDNA | c.2053C>T |
| Protein | p.Q685* |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_047436895.1 | chr17:g.61776505G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| NM_032043.3 | chr17:g.61776445G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525340.3 | chr17:g.61776505G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525333.3 | chr17:g.61776505G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_047436891.1 | chr17:g.61776445G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525332.3 | chr17:g.61776505G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525339.3 | chr17:g.61776505G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_047436900.1 | chr17:g.61776445G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525332 | chr17:g.61776505G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525340.4 | chr17:g.61776505G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525339.4 | chr17:g.61776505G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_047436901.1 | chr17:g.61776445G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525340 | chr17:g.61776505G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| NM_032043 | chr17:g.61776445G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525335.3 | chr17:g.61776445G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525334.2 | chr17:g.61776505G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525334.3 | chr17:g.61776505G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_047436899.1 | chr17:g.61776445G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525339 | chr17:g.61776505G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525332.4 | chr17:g.61776505G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_047436892.1 | chr17:g.61776445G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_047436896.1 | chr17:g.61776445G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525335.4 | chr17:g.61776445G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| NM_032043.2 | chr17:g.61776445G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525335 | chr17:g.61776445G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_047436897.1 | chr17:g.61776445G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525334 | chr17:g.61776505G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525333 | chr17:g.61776505G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| XM_011525333.4 | chr17:g.61776505G>A | c.2053C>T | p.Q685* | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| BRIP1 Q685* | Advanced Solid Tumor | sensitive | Cisplatin | Preclinical - Cell culture | Actionable | In a preclinical study, Platinol (cisplatin) treatment inhibited viability of a cell line expressing BRIP1 Q685* in culture (PMID: 33619228). | 33619228 |